Pharmacology of Basimglurant (RO4917523, RG7090), a Unique Metabotropic Glutamate Receptor 5 Negative Allosteric Modulator in Clinical Development for Depression
Major depressive disorder (MDD) is a serious public health burden and a leading cause of disability. Its pharmacotherapy is currently limited to modulators of monoamine neurotransmitters and second-generation antipsychotics. Recently, glutamatergic approaches for the treatment of MDD have increasing...
Saved in:
| Published in | The Journal of pharmacology and experimental therapeutics Vol. 353; no. 1; pp. 213 - 233 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Elsevier Inc
01.04.2015
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0022-3565 1521-0103 1521-0103 |
| DOI | 10.1124/jpet.114.222463 |
Cover
| Abstract | Major depressive disorder (MDD) is a serious public health burden and a leading cause of disability. Its pharmacotherapy is currently limited to modulators of monoamine neurotransmitters and second-generation antipsychotics. Recently, glutamatergic approaches for the treatment of MDD have increasingly received attention, and preclinical research suggests that metabotropic glutamate receptor 5 (mGlu5) inhibitors have antidepressant-like properties. Basimglurant (2-chloro-4-[1-(4-fluoro-phenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]-pyridine) is a novel mGlu5 negative allosteric modulator currently in phase 2 clinical development for MDD and fragile X syndrome. Here, the comprehensive preclinical pharmacological profile of basimglurant is presented with a focus on its therapeutic potential for MDD and drug-like properties. Basimglurant is a potent, selective, and safe mGlu5 inhibitor with good oral bioavailability and long half-life supportive of once-daily administration, good brain penetration, and high in vivo potency. It has antidepressant properties that are corroborated by its functional magnetic imaging profile as well as anxiolytic-like and antinociceptive features. In electroencephalography recordings, basimglurant shows wake-promoting effects followed by increased delta power during subsequent non–rapid eye movement sleep. In microdialysis studies, basimglurant had no effect on monoamine transmitter levels in the frontal cortex or nucleus accumbens except for a moderate increase of accumbal dopamine, which is in line with its lack of pharmacological activity on monoamine reuptake transporters. These data taken together, basimglurant has favorable drug-like properties, a differentiated molecular mechanism of action, and antidepressant-like features that suggest the possibility of also addressing important comorbidities of MDD including anxiety and pain as well as daytime sleepiness and apathy or lethargy. |
|---|---|
| AbstractList | Major depressive disorder (MDD) is a serious public health burden and a leading cause of disability. Its pharmacotherapy is currently limited to modulators of monoamine neurotransmitters and second-generation antipsychotics. Recently, glutamatergic approaches for the treatment of MDD have increasingly received attention, and preclinical research suggests that metabotropic glutamate receptor 5 (mGlu5) inhibitors have antidepressant-like properties. Basimglurant (2-chloro-4-[1-(4-fluoro-phenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]-pyridine) is a novel mGlu5 negative allosteric modulator currently in phase 2 clinical development for MDD and fragile X syndrome. Here, the comprehensive preclinical pharmacological profile of basimglurant is presented with a focus on its therapeutic potential for MDD and drug-like properties. Basimglurant is a potent, selective, and safe mGlu5 inhibitor with good oral bioavailability and long half-life supportive of once-daily administration, good brain penetration, and high in vivo potency. It has antidepressant properties that are corroborated by its functional magnetic imaging profile as well as anxiolytic-like and antinociceptive features. In electroencephalography recordings, basimglurant shows wake-promoting effects followed by increased delta power during subsequent non–rapid eye movement sleep. In microdialysis studies, basimglurant had no effect on monoamine transmitter levels in the frontal cortex or nucleus accumbens except for a moderate increase of accumbal dopamine, which is in line with its lack of pharmacological activity on monoamine reuptake transporters. These data taken together, basimglurant has favorable drug-like properties, a differentiated molecular mechanism of action, and antidepressant-like features that suggest the possibility of also addressing important comorbidities of MDD including anxiety and pain as well as daytime sleepiness and apathy or lethargy. Major depressive disorder (MDD) is a serious public health burden and a leading cause of disability. Its pharmacotherapy is currently limited to modulators of monoamine neurotransmitters and second-generation antipsychotics. Recently, glutamatergic approaches for the treatment of MDD have increasingly received attention, and preclinical research suggests that metabotropic glutamate receptor 5 (mGlu5) inhibitors have antidepressant-like properties. Basimglurant (2-chloro-4-[1-(4-fluoro-phenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]-pyridine) is a novel mGlu5 negative allosteric modulator currently in phase 2 clinical development for MDD and fragile X syndrome. Here, the comprehensive preclinical pharmacological profile of basimglurant is presented with a focus on its therapeutic potential for MDD and drug-like properties. Basimglurant is a potent, selective, and safe mGlu5 inhibitor with good oral bioavailability and long half-life supportive of once-daily administration, good brain penetration, and high in vivo potency. It has antidepressant properties that are corroborated by its functional magnetic imaging profile as well as anxiolytic-like and antinociceptive features. In electroencephalography recordings, basimglurant shows wake-promoting effects followed by increased delta power during subsequent non-rapid eye movement sleep. In microdialysis studies, basimglurant had no effect on monoamine transmitter levels in the frontal cortex or nucleus accumbens except for a moderate increase of accumbal dopamine, which is in line with its lack of pharmacological activity on monoamine reuptake transporters. These data taken together, basimglurant has favorable drug-like properties, a differentiated molecular mechanism of action, and antidepressant-like features that suggest the possibility of also addressing important comorbidities of MDD including anxiety and pain as well as daytime sleepiness and apathy or lethargy.Major depressive disorder (MDD) is a serious public health burden and a leading cause of disability. Its pharmacotherapy is currently limited to modulators of monoamine neurotransmitters and second-generation antipsychotics. Recently, glutamatergic approaches for the treatment of MDD have increasingly received attention, and preclinical research suggests that metabotropic glutamate receptor 5 (mGlu5) inhibitors have antidepressant-like properties. Basimglurant (2-chloro-4-[1-(4-fluoro-phenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]-pyridine) is a novel mGlu5 negative allosteric modulator currently in phase 2 clinical development for MDD and fragile X syndrome. Here, the comprehensive preclinical pharmacological profile of basimglurant is presented with a focus on its therapeutic potential for MDD and drug-like properties. Basimglurant is a potent, selective, and safe mGlu5 inhibitor with good oral bioavailability and long half-life supportive of once-daily administration, good brain penetration, and high in vivo potency. It has antidepressant properties that are corroborated by its functional magnetic imaging profile as well as anxiolytic-like and antinociceptive features. In electroencephalography recordings, basimglurant shows wake-promoting effects followed by increased delta power during subsequent non-rapid eye movement sleep. In microdialysis studies, basimglurant had no effect on monoamine transmitter levels in the frontal cortex or nucleus accumbens except for a moderate increase of accumbal dopamine, which is in line with its lack of pharmacological activity on monoamine reuptake transporters. These data taken together, basimglurant has favorable drug-like properties, a differentiated molecular mechanism of action, and antidepressant-like features that suggest the possibility of also addressing important comorbidities of MDD including anxiety and pain as well as daytime sleepiness and apathy or lethargy. |
| Author | Vieira, Eric Kuennecke, Basil von Kienlin, Markus Funk, Christoph Niederhauser, Urs Paehler, Axel Honer, Michael Porter, Richard H. Gloge, Andreas Morairty, Stephen R. Jaeschke, Georg Bruns, Andreas Lindemann, Lothar Schneider, Manfred Kolczewski, Sabine Moreau, Jean-Luc Kilduff, Thomas S. Wichmann, Juergen Prinssen, Eric Wettstein, Joseph G. Spooren, Will Hartung, Thomas Parrott, Neil J. Harrison, Anthony C. Scharf, Sebastian H. Polonchuk, Liudmila Borroni, Edilio |
| Author_xml | – sequence: 1 givenname: Lothar surname: Lindemann fullname: Lindemann, Lothar – sequence: 2 givenname: Richard H. surname: Porter fullname: Porter, Richard H. – sequence: 3 givenname: Sebastian H. surname: Scharf fullname: Scharf, Sebastian H. – sequence: 4 givenname: Basil surname: Kuennecke fullname: Kuennecke, Basil – sequence: 5 givenname: Andreas surname: Bruns fullname: Bruns, Andreas – sequence: 6 givenname: Markus surname: von Kienlin fullname: von Kienlin, Markus – sequence: 7 givenname: Anthony C. surname: Harrison fullname: Harrison, Anthony C. – sequence: 8 givenname: Axel surname: Paehler fullname: Paehler, Axel – sequence: 9 givenname: Christoph surname: Funk fullname: Funk, Christoph – sequence: 10 givenname: Andreas surname: Gloge fullname: Gloge, Andreas – sequence: 11 givenname: Manfred surname: Schneider fullname: Schneider, Manfred – sequence: 12 givenname: Neil J. surname: Parrott fullname: Parrott, Neil J. – sequence: 13 givenname: Liudmila surname: Polonchuk fullname: Polonchuk, Liudmila – sequence: 14 givenname: Urs surname: Niederhauser fullname: Niederhauser, Urs – sequence: 15 givenname: Stephen R. surname: Morairty fullname: Morairty, Stephen R. – sequence: 16 givenname: Thomas S. surname: Kilduff fullname: Kilduff, Thomas S. – sequence: 17 givenname: Eric surname: Vieira fullname: Vieira, Eric – sequence: 18 givenname: Sabine surname: Kolczewski fullname: Kolczewski, Sabine – sequence: 19 givenname: Juergen surname: Wichmann fullname: Wichmann, Juergen – sequence: 20 givenname: Thomas surname: Hartung fullname: Hartung, Thomas – sequence: 21 givenname: Michael surname: Honer fullname: Honer, Michael – sequence: 22 givenname: Edilio surname: Borroni fullname: Borroni, Edilio – sequence: 23 givenname: Jean-Luc surname: Moreau fullname: Moreau, Jean-Luc – sequence: 24 givenname: Eric surname: Prinssen fullname: Prinssen, Eric – sequence: 25 givenname: Will surname: Spooren fullname: Spooren, Will – sequence: 26 givenname: Joseph G. surname: Wettstein fullname: Wettstein, Joseph G. – sequence: 27 givenname: Georg surname: Jaeschke fullname: Jaeschke, Georg |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25665805$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kUFv1DAQhS1URLeFMzfkY5Ga1nbsJD6WLSxILUUrerYcZ3Zx5dip7azUn8M_xattL0g9zUjzvRnNeyfoyAcPCH2k5IJSxi8fJsil4xeMMd7Ub9CCCkYrQkl9hBaEMFbVohHH6CSlB0IoL9A7dMxE04iOiAX6--uPjqM2wYXtEw4b_EUnO27dHLXP-Gx9xyVtBavP8XrVEkk-n2ON7719nAHfQtZ9yDFM1uCVm7MedQa8BgNTDhEL_BO2Otsd4CvnQsoQC3gbhtnp_dx6vHTWW6MdvoYduDCNUK5uyuwapggp2eDfo7cb7RJ8eK6n6P7b19_L79XN3erH8uqmMnVb56pjRg8bqTuhScc56LrtGW9l3xPW0K4f2qEZpBwk77pakmJAQ6SmjSSmfNi39Sk6O-ydYijfpaxGmww4pz2EOSnaNFRKwiUp6KdndO5HGNQU7ajjk3qxtQDiAJgYUoqwUcbm4kTwOWrrFCVqH5_ax1c6rg7xFd3lf7qX1a8r5EEBxZqdhaiSseANDDaCyWoI9lXtP2n_r3A |
| CitedBy_id | crossref_primary_10_1080_13543776_2017_1280466 crossref_primary_10_3389_fnins_2021_700822 crossref_primary_10_3389_fphar_2022_884155 crossref_primary_10_1016_j_bmcl_2017_08_030 crossref_primary_10_12677_PI_2016_52007 crossref_primary_10_1021_acschemneuro_9b00415 crossref_primary_10_1111_jnc_14290 crossref_primary_10_1124_mol_119_119032 crossref_primary_10_1159_000443175 crossref_primary_10_3390_ph16081127 crossref_primary_10_1021_acschembio_2c00234 crossref_primary_10_3390_ijms20184552 crossref_primary_10_1016_j_bmcl_2018_11_017 crossref_primary_10_3390_ijms20061412 crossref_primary_10_3390_biomedicines11123241 crossref_primary_10_1038_npp_2017_177 crossref_primary_10_1016_j_biopsych_2018_03_001 crossref_primary_10_2174_1381612825666191102165206 crossref_primary_10_1038_npp_2015_265 crossref_primary_10_1042_CS20180374 crossref_primary_10_1021_acs_jmedchem_5b00892 crossref_primary_10_1016_j_neuropharm_2021_108687 crossref_primary_10_1080_14728222_2020_1836160 crossref_primary_10_1111_bph_13281 crossref_primary_10_1177_10738584211021018 crossref_primary_10_1016_j_pbb_2022_173446 crossref_primary_10_1021_acsptsci_4c00213 crossref_primary_10_1093_toxsci_kfaa076 crossref_primary_10_1177_2470547019837712 crossref_primary_10_1016_j_nlm_2018_10_001 crossref_primary_10_1002_jlcr_3802 crossref_primary_10_1038_nrd_2017_221 crossref_primary_10_1517_13543784_2015_1074175 crossref_primary_10_1016_j_neuroscience_2024_10_004 crossref_primary_10_1016_j_neuropharm_2017_03_036 crossref_primary_10_1080_14737175_2017_1341310 crossref_primary_10_1093_ijnp_pyw002 crossref_primary_10_3390_cells10061375 crossref_primary_10_1016_j_phrs_2016_11_029 crossref_primary_10_1016_j_bmcl_2016_03_026 crossref_primary_10_1021_acs_jmedchem_8b01226 crossref_primary_10_1007_s11940_019_0551_8 crossref_primary_10_1111_ejn_15495 crossref_primary_10_1124_jpet_116_237214 crossref_primary_10_1007_s00429_019_01937_2 crossref_primary_10_1021_acsmedchemlett_4c00481 crossref_primary_10_1038_s41598_017_09991_8 crossref_primary_10_3389_fnmol_2018_00376 crossref_primary_10_1016_j_neuropharm_2016_04_044 crossref_primary_10_1002_syn_22126 crossref_primary_10_1016_j_bbi_2016_08_007 crossref_primary_10_1080_14728222_2018_1480723 crossref_primary_10_2174_1385272823666191014154129 crossref_primary_10_1021_acschemneuro_8b00059 crossref_primary_10_1016_j_celrep_2016_04_077 crossref_primary_10_1021_acs_jmedchem_7b00410 crossref_primary_10_1177_0269881116672342 crossref_primary_10_1016_j_bmcl_2016_01_051 crossref_primary_10_3390_cells12151952 crossref_primary_10_3390_pharmaceutics15092208 crossref_primary_10_1007_s00259_015_3301_5 crossref_primary_10_1007_s40501_021_00249_9 crossref_primary_10_1007_s11920_018_0871_5 crossref_primary_10_1016_j_coph_2018_02_001 crossref_primary_10_1111_cts_12566 crossref_primary_10_1016_j_ejphar_2021_174231 crossref_primary_10_1007_s00213_024_06571_3 crossref_primary_10_1016_j_pharmthera_2018_08_010 crossref_primary_10_1124_jpet_120_000371 crossref_primary_10_1016_j_psychres_2017_07_059 crossref_primary_10_1080_17460441_2016_1213234 crossref_primary_10_3390_brainsci9050096 crossref_primary_10_1111_bph_15753 crossref_primary_10_1016_j_ejmhg_2016_01_005 crossref_primary_10_1111_bph_15515 crossref_primary_10_1155_2017_4605971 crossref_primary_10_1016_j_ejmech_2023_115855 crossref_primary_10_1080_13543784_2017_1267727 |
| Cites_doi | 10.1016/0304-3959(88)90209-6 10.1038/sj.npp.1300540 10.1124/jpet.111.185660 10.1016/j.biopsych.2013.03.026 10.1073/pnas.89.1.212 10.1016/j.mrgentox.2010.03.018 10.1038/sj.bjp.0704698 10.1002/em.2860120404 10.1016/S0924-8196(00)80044-5 10.1016/0014-2999(78)90118-8 10.1016/j.physbeh.2005.02.011 10.1038/349760a0 10.1016/j.bmc.2006.10.038 10.1371/journal.pone.0036476 10.1002/(SICI)1522-2594(199907)42:1<206::AID-MRM28>3.0.CO;2-Q 10.1016/S0014-2999(97)00070-8 10.1113/jphysiol.2011.215657 10.1126/science.1656524 10.1002/da.22227 10.1016/j.bbr.2010.12.024 10.1517/13543776.2014.983899 10.2174/187231210791292753 10.2307/2556164 10.1002/hup.726 10.1038/nn.2647 10.1016/0924-977X(92)90035-7 10.1016/j.vascn.2010.08.003 10.1523/JNEUROSCI.2559-08.2009 10.1016/j.neuropharm.2012.08.001 10.2307/2528930 10.1006/exnr.1999.7124 10.1016/j.ejphar.2010.02.058 10.1016/j.bmc.2014.09.033 10.1007/s00213-008-1191-y 10.1016/0013-4694(86)90044-1 10.1016/j.neubiorev.2012.07.001 10.1046/j.1460-9568.2003.02657.x 10.1002/cne.20158 10.1517/13543784.2014.931370 10.1177/0269881113513850 10.1007/s00213-005-2211-9 10.1016/S0306-3623(96)00359-X 10.1016/j.biopsych.2013.05.038 10.1016/0924-977X(96)00015-6 10.1021/jm025570j 10.1097/00004714-198204000-00010 10.1038/nn.3103 10.1016/j.pbb.2013.05.016 10.1097/00004647-199611000-00019 10.1016/j.pnpbp.2013.04.009 10.1016/j.pbb.2012.03.022 10.1002/mrm.1910030602 10.1016/S0022-3565(24)37366-5 10.1016/S0090-4295(01)01633-8 10.1124/jpet.106.116483 10.1093/sleep/31.1.34 10.1007/s00213-004-2126-x 10.1177/0091270010394852 10.1146/annurev-med-061109-134644 10.3389/fphar.2012.00199 10.1517/13543776.18.2.123 10.1016/0304-3959(92)90041-9 10.1016/j.neuropharm.2013.06.020 10.1007/s00213-014-3746-4 10.1016/j.neulet.2008.11.026 10.1124/jpet.113.211185 10.1016/B978-0-444-52006-7.00013-7 10.31887/DCNS.2002.4.4/jlmoreau 10.1016/S0091-3057(02)00829-8 10.1016/j.jmr.2011.09.021 10.1016/S0140-6736(11)60602-8 10.1097/00008877-199511000-00003 10.1016/j.neuron.2012.03.009 10.1016/S0924-977X(14)70748-5 10.1016/S0090-9556(25)06747-9 10.1002/mds.25561 10.1016/j.neuropharm.2012.04.007 10.1002/mrm.21779 10.1016/S0014-2999(01)01562-X 10.1016/j.neuroscience.2012.05.064 10.1016/j.neuroscience.2012.08.010 10.1007/978-1-61779-909-9_8 10.1016/j.neuropharm.2004.01.018 10.1016/S1734-1140(13)71522-6 10.1016/S0028-3908(02)00082-5 10.1016/S0022-3565(24)39013-5 10.1124/jpet.106.103143 10.1124/jpet.105.089839 10.1176/appi.ajp.2010.10111677 10.1021/jm501642c 10.1016/S0896-6273(02)00653-0 10.1038/nn.3118 10.1186/1744-8069-8-20 10.1016/S0891-0618(97)00051-3 10.1016/j.neuropharm.2011.07.036 10.1016/j.biopsych.2006.07.007 10.1093/mutage/geg006 10.1016/S0028-3908(99)00082-9 10.1001/archpsyc.63.8.856 10.1016/j.neuropharm.2009.12.004 10.1016/j.pnpbp.2012.09.011 10.1016/j.coph.2014.11.004 10.1038/npp.2014.13 10.1038/nrn3381 |
| ContentType | Journal Article |
| Copyright | 2015 American Society for Pharmacology and Experimental Therapeutics Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics. |
| Copyright_xml | – notice: 2015 American Society for Pharmacology and Experimental Therapeutics – notice: Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1124/jpet.114.222463 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1521-0103 |
| EndPage | 233 |
| ExternalDocumentID | 25665805 10_1124_jpet_114_222463 S0022356524189902 |
| Genre | Journal Article |
| GroupedDBID | --- -~X .55 .GJ 0R~ 18M 2WC 3O- 4.4 53G 5GY 5RE 5VS 8WZ A6W AAJMC AALRI AAXUO AAYOK ABCQX ABIVO ABJNI ABOCM ABSQV ACGFO ACGFS ACNCT ADBBV ADCOW ADIYS AENEX AERNN AFFNX AFHIN AFOSN AGFXO AI. ALMA_UNASSIGNED_HOLDINGS BAWUL BTFSW CS3 DIK DU5 E3Z EBS EJD F5P F9R FDB GX1 H13 HZ~ INIJC KQ8 L7B LSO M41 MJL MVM O9- OHT OK1 P2P PKN R.V R0Z RHF RHI ROL RPT TR2 UQL VH1 W2D W8F WH7 WOQ X7M YBU YHG YQT ZGI ZXP AAYXX ACVFH ADCNI AETEA AEUPX AFPUW AIGII AKBMS AKYEP CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c373t-82cadf9a85a0844ea37b2479bb02618bd7d6d99d9488390566609a1690c917b73 |
| ISSN | 0022-3565 1521-0103 |
| IngestDate | Sat Sep 27 18:06:58 EDT 2025 Sat Mar 08 01:25:22 EST 2025 Wed Sep 10 04:21:35 EDT 2025 Thu Apr 24 23:02:08 EDT 2025 Sat Feb 15 15:51:28 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | FXS CTEP FPS MDD ANOVA ICSS GRN-529 hERG EEG FST IP PMC CMS MPEP ROI AFQ056 CER fMRI mGlu SSRI E-4031 SNRI ABP688 MTEP ECT NE RMS ZT NAM PK REM 5-HT DA |
| Language | English |
| License | Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c373t-82cadf9a85a0844ea37b2479bb02618bd7d6d99d9488390566609a1690c917b73 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 25665805 |
| PQID | 1661990490 |
| PQPubID | 23479 |
| PageCount | 21 |
| ParticipantIDs | proquest_miscellaneous_1661990490 pubmed_primary_25665805 crossref_citationtrail_10_1124_jpet_114_222463 crossref_primary_10_1124_jpet_114_222463 elsevier_sciencedirect_doi_10_1124_jpet_114_222463 |
| PublicationCentury | 2000 |
| PublicationDate | 2015-04-01 |
| PublicationDateYYYYMMDD | 2015-04-01 |
| PublicationDate_xml | – month: 04 year: 2015 text: 2015-04-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | The Journal of pharmacology and experimental therapeutics |
| PublicationTitleAlternate | J Pharmacol Exp Ther |
| PublicationYear | 2015 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| References | Deichmann, Hahn, Haase (bib27) 1999; 42 Fleury, Lavé, Jonsson, Schmitt, Hirkaler, Polonchuk, Breidenbach (bib32) 2011; 63 Gasparini, Bilbe, Gomez-Mancilla, Spooren (bib33) 2008; 11 Kuwajima, Hall, Aiba, Smith (bib61) 2004; 474 (bib5) 2000 Kim, Chung (bib44) 1992; 50 Hughes, Neal, Smith, Sukoff Rizzo, Pulicicchio, Lotarski, Lu, Dwyer, Brennan, Olsen (bib50) 2013; 66 Basile, Janowsky, Golembiowska, Kowalska, Tam, Benveniste, Popik, Nikiforuk, Krawczyk, Nowak (bib10) 2007; 321 Nestler, Hyman (bib82) 2010; 13 Lopes, da Silva, Arruda, Morais, Rios, Trevisan, Rao, Santos (bib66) 2013; 110 Jaeschke G, Kolczewski S, Spooren W, Vieira E, Bitter-Stoll N, Boissin P, Borroni E, Buttelmann B, Ceccarelli S, Clemann N, et al. (2015) Metabotropic glutamate receptor 5 negative allosteric modulators: discovery of 2-chloro-4-[1-(4-fluorophenyl)-2,5-dimethyl-1 Larson, Ogagan, Chen, Shen, Wang, Roppolo, de Groat, Tai (bib62) 2011; 589 Shigemoto, Mizuno (bib100) 2000 Yoshiyama, Nezu, Yokoyama, Chancellor, de Groat (bib114) 1999; 159 Krueger, Bear (bib57) 2011; 62 Hennig, Nauerth, Friedburg (bib40) 1986; 3 Kubera, Hernandez, Heng, Bordey (bib59) 2012; 219 Li, Need, Baez, Witkin (bib63) 2006; 319 Ballard, Woolley, Prinssen, Huwyler, Porter, Spooren (bib9) 2005; 179 Luján, Roberts, Shigemoto, Ohishi, Somogyi (bib67) 1997; 13 Pecknold, McClure, Appeltauer, Wrzesinski, Allan (bib85) 1982; 2 Tronci, Balfour (bib108) 2011; 219 Moreau (bib76) 2002; 4 Sanacora, Treccani, Popoli (bib97) 2012; 62 Valles, Schiller, Coassolo, De Sousa, Wyss, Jaeck, Viger-Chougnet, Rahmani (bib109) 1995; 23 Goeldner, Ballard, Knoflach, Wichmann, Gatti, Umbricht (bib35) 2013; 64 Ahnaou A, Langlois X, Steckler T, Bartolome-Nebreda JM, Drinkenburg WH (2014) Negative versus positive allosteric modulation of metabotropic glutamate receptors (mGluR5): indices for potential pro-cognitive drug properties based on EEG network oscillations and sleep-wake organization in rats. Swedberg, Ellgren, Raboisson (bib105) 2014; 349 Spinelli, Ballard, Gatti-McArthur, Richards, Kapps, Woltering, Wichmann, Stadler, Feldon, Pryce (bib101) 2005; 179 Cosford, Tehrani, Roppe, Schweiger, Smith, Anderson, Bristow, Brodkin, Jiang, McDonald (bib22) 2003; 46 Ahmadi, Saleh, Shapiro (bib1) 2010 Williams (bib112) 1972; 28 Covington, Vialou, Nestler (bib23) 2010; 58 Williams, Detre, Leigh, Koretsky (bib113) 1992; 89 Alsop, Detre (bib4) 1996; 16 Hysek, Simmler, Nicola, Vischer, Donzelli, Krähenbühl, Grouzmann, Huwyler, Hoener, Liechti (bib52) 2012; 7 Crock, Stemler, Song, Abbosh, Vogt, Qiu, Lai, Mysorekar, Gereau (bib24) 2012; 8 Piers, Kim, Kim, Regan, Whitcomb, Cho (bib88) 2012; 3 Lindemann, Jaeschke, Michalon, Vieira, Honer, Spooren, Porter, Hartung, Kolczewski, Büttelmann (bib64) 2011; 339 Spooren, Schoeffter, Gasparini, Kuhn, Gentsch (bib102) 2002; 435 Bespalov, van Gaalen, Gross (bib14) 2010 Blok (bib15) 2002; 59 Cavas, Scesa, Navarro (bib20) 2013; 40 Buettelmann B, Ceccarelli SM, Jaeschke G, Kolczewski S, Porter RHP, Vieira E, Ford APDW, and Zhong Y (2005), inventors, F. Hoffmann-La Roche AG, assignee. Imidazole derivatives. U.S. patent 11/020,451 US20050143375 A1. 2005 Jun 30. Petersen, Bomme, Baastrup, Kemp, Christoffersen (bib86) 2002; 73 Holderbach, Clark, Moreau, Bischofberger, Normann (bib45) 2007; 62 Rowley, Kulkarni, Gosden, Brammer, Hackett, Heal (bib95) 2014; 28 Mayers, Baldwin (bib70) 2005; 20 Marek (bib68) 2010; 639 Moreau, Scherschlicht, Jenck, Martin (bib79) 1995; 6 DOI: 10.1007/s00213-014-3746-4 [published ahead of print]. Staner, Staner, Luthringer (bib103) 2010 Monteggia (bib74) 2011; 168 Vranesic, Ofner, Flor, Bilbe, Bouhelal, Enz, Desrayaud, McAllister, Kuhn, Gasparini (bib110) 2014; 22 Cryan, Lucki (bib25) 2000; 295 Grippo, Francis, Beltz, Felder, Johnson (bib36) 2005; 84 Hsieh, Ho, Yeh, Pawlak, Chang, Ho, Lai, Wu (bib47) 2012; 102 Morairty, Hedley, Flores, Martin, Kilduff (bib75) 2008; 31 Albertini, Gocke (bib3) 1988; 12 Haase, Frahm, Matthaei, Hänicke, Merboldt (bib37) 2011; 213 Busse, Brodkin, Tattersall, Anderson, Warren, Tehrani, Bristow, Varney, Cosford (bib19) 2004; 29 Masu, Tanabe, Tsuchida, Shigemoto, Nakanishi (bib69) 1991; 349 Dang, Naeem, Walker, Bowery, Urban (bib26) 2002; 136 Porter, Jaeschke, Spooren, Ballard, Büttelmann, Kolczewski, Peters, Prinssen, Wichmann, Vieira (bib92) 2005; 315 Krystal, Sanacora, Duman (bib58) 2013; 73 Moreau, Bös, Jenck, Martin, Mortas, Wichmann (bib77) 1996; 6 Duman (bib30) 2014; 31 Beitinger, Fulda (bib12) 2010 Radulovic, Tronson (bib94) 2012; 15 Jaeschke, Wettstein, Nordquist, Spooren (bib54) 2008; 18 Russo, Nestler (bib96) 2013; 14 Kupfer, Frank, Phillips (bib60) 2012; 379 Fitch, Chen, Liu, Paehler, Young (bib31) 2010; 4 Quiroz, Tamburri, Deptula, Banken, Beyer, Fontoura, Santarelli (bib93) 2014; 24 Hintermann, Vranesic, Allgeier, Brülisauer, Hoyer, Lemaire, Moenius, Urwyler, Whitebread, Gasparini (bib43) 2007; 15 Tobler, Borbély (bib106) 1986; 64 Celanire, Sebhat, Wichmann, Mayer, Schann, Gatti (bib21) 2015; 25 Dharmshaktu, Tayal, Kalra (bib28) 2012; 52 DOI: 10.1021/jm501642c [published ahead of print]. Borbély, Tobler (bib16) 2011; 98 Porsolt, Anton, Blavet, Jalfre (bib91) 1978; 47 Zarate, Singh, Carlson, Brutsche, Ameli, Luckenbaugh, Charney, Manji (bib115) 2006; 63 imidazol-4-ylethynyl]pyridine (basimglurant, RO4917523), a promising novel medicine for psychiatric diseases. Kakizaki, Yoshiyama, Roppolo, Booth, De Groat (bib55) 1998; 285 Hu, Dong, Sun, Guillon, Burbach, Nunn, Liu, Vilenski, Ford, Zhong (bib49) 2009; 450 Paxinos (bib84) 1986 Hill, Hellemans, Verma, Gorzalka, Weinberg (bib42) 2012; 36 Hu, Yang, Kammermeier, Moore, Brakeman, Tu, Yu, Petralia, Li, Zhang (bib48) 2012; 15 Hunter, Gogas, Hedley, Jacobson, Kassotakis, Thompson, Fontana (bib51) 1997; 324 Houamed, Kuijper, Gilbert, Haldeman, O’Hara, Mulvihill, Almers, Hagen (bib46) 1991; 252 Tokunaga, Seneca, Shin, Maeda, Obayashi, Okauchi, Nagai, Zhang, Nakao, Ito (bib107) 2009; 29 Scharf, Jaeschke, Wettstein, Lindemann (bib98) 2015; 20C O’Donnel, Shelton (bib83) 2011 Platt, Rowlett, Spealman (bib90) 2008; 200 Stocchi, Rascol, Destee, Hattori, Hauser, Lang, Poewe, Stacy, Tolosa, Gao (bib104) 2013; 28 Muster, Albertini, Gocke (bib80) 2003; 18 Bennett, Xie (bib13) 1988; 33 Petrov, Pedros, de Lemos, Pallàs, Canudas, Lazarowski, Beas-Zarate, Auladell, Folch, Camins (bib87) 2014; 23 Nestler, Barrot, DiLeone, Eisch, Gold, Monteggia (bib81) 2002; 34 Higgins, Ballard, Kew, Richards, Kemp, Adam, Woltering, Nakanishi, Mutel (bib41) 2004; 46 Kirchner, Zeller (bib56) 2010; 702 Moreau, Jenck, Martin, Mortas, Haefely (bib78) 1992; 2 Aronica, Gorter, Ijlst-Keizers, Rozemuller, Yankaya, Leenstra, Troost (bib8) 2003; 17 Ametamey, Kessler, Honer, Wyss, Buck, Hintermann, Auberson, Gasparini, Schubiger (bib6) 2006; 47 Bruns, Künnecke, Risterucci, Moreau, von Kienlin (bib17) 2009; 61 Bassoni, Jafri, Sastry, Mathrubutham, Wehrman (bib11) 2012; 897 Williams (bib111) 1971; 27 Ametamey, Treyer, Streffer, Wyss, Schmidt, Blagoev, Hintermann, Auberson, Gasparini, Fischer (bib7) 2007; 48 Pilc, Kłodzińska, Brański, Nowak, Pałucha, Szewczyk, Tatarczyńska, Chojnacka-Wójcik, Wierońska (bib89) 2002; 43 Mika, Zychowska, Makuch, Rojewska, Przewlocka (bib73) 2013; 65 Hamon, Blier (bib38) 2013; 45 Harvey, Siok, Kiss, Volfson, Grimwood, Shaffer, Hajós (bib39) 2013; 75 Seese, Maske, Lynch, Gall (bib99) 2014; 39 Liu, Jiang, Zhu, Wei (bib65) 2012; 223 Michalon, Sidorov, Ballard, Ozmen, Spooren, Wettstein, Jaeschke, Bear, Lindemann (bib72) 2012; 74 Dickenson, Chapman, Green (bib29) 1997; 28 Gasparini, Lingenhöhl, Stoehr, Flor, Heinrich, Vranesic, Biollaz, Allgeier, Heckendorn, Urwyler (bib34) 1999; 38 Michalon, Bruns, Risterucci, Honer, Ballard, Ozmen, Jaeschke, Wettstein, von Kienlin, Künnecke (bib71) 2014; 75 Deichmann (10.1124/jpet.114.222463_bib27) 1999; 42 Bespalov (10.1124/jpet.114.222463_bib14) 2010 Mayers (10.1124/jpet.114.222463_bib70) 2005; 20 Platt (10.1124/jpet.114.222463_bib90) 2008; 200 Spooren (10.1124/jpet.114.222463_bib102) 2002; 435 Vranesic (10.1124/jpet.114.222463_bib110) 2014; 22 Hsieh (10.1124/jpet.114.222463_bib47) 2012; 102 Muster (10.1124/jpet.114.222463_bib80) 2003; 18 Haase (10.1124/jpet.114.222463_bib37) 2011; 213 Li (10.1124/jpet.114.222463_bib63) 2006; 319 Quiroz (10.1124/jpet.114.222463_bib93) 2014; 24 Houamed (10.1124/jpet.114.222463_bib46) 1991; 252 Bassoni (10.1124/jpet.114.222463_bib11) 2012; 897 Yoshiyama (10.1124/jpet.114.222463_bib114) 1999; 159 Fleury (10.1124/jpet.114.222463_bib32) 2011; 63 Williams (10.1124/jpet.114.222463_bib113) 1992; 89 Spinelli (10.1124/jpet.114.222463_bib101) 2005; 179 Nestler (10.1124/jpet.114.222463_bib82) 2010; 13 Liu (10.1124/jpet.114.222463_bib65) 2012; 223 Mika (10.1124/jpet.114.222463_bib73) 2013; 65 Busse (10.1124/jpet.114.222463_bib19) 2004; 29 Luján (10.1124/jpet.114.222463_bib67) 1997; 13 Shigemoto (10.1124/jpet.114.222463_bib100) 2000 Dickenson (10.1124/jpet.114.222463_bib29) 1997; 28 Ametamey (10.1124/jpet.114.222463_bib6) 2006; 47 Harvey (10.1124/jpet.114.222463_bib39) 2013; 75 Holderbach (10.1124/jpet.114.222463_bib45) 2007; 62 Crock (10.1124/jpet.114.222463_bib24) 2012; 8 (10.1124/jpet.114.222463_bib5) 2000 Krueger (10.1124/jpet.114.222463_bib57) 2011; 62 Porter (10.1124/jpet.114.222463_bib92) 2005; 315 Tronci (10.1124/jpet.114.222463_bib108) 2011; 219 Moreau (10.1124/jpet.114.222463_bib79) 1995; 6 Larson (10.1124/jpet.114.222463_bib62) 2011; 589 Hennig (10.1124/jpet.114.222463_bib40) 1986; 3 Ahmadi (10.1124/jpet.114.222463_bib1) 2010 Monteggia (10.1124/jpet.114.222463_bib74) 2011; 168 Sanacora (10.1124/jpet.114.222463_bib97) 2012; 62 10.1124/jpet.114.222463_bib2 Pilc (10.1124/jpet.114.222463_bib89) 2002; 43 Williams (10.1124/jpet.114.222463_bib111) 1971; 27 Kirchner (10.1124/jpet.114.222463_bib56) 2010; 702 Ametamey (10.1124/jpet.114.222463_bib7) 2007; 48 Alsop (10.1124/jpet.114.222463_bib4) 1996; 16 Aronica (10.1124/jpet.114.222463_bib8) 2003; 17 Kubera (10.1124/jpet.114.222463_bib59) 2012; 219 10.1124/jpet.114.222463_bib53 Russo (10.1124/jpet.114.222463_bib96) 2013; 14 Scharf (10.1124/jpet.114.222463_bib98) 2015; 20C Stocchi (10.1124/jpet.114.222463_bib104) 2013; 28 Swedberg (10.1124/jpet.114.222463_bib105) 2014; 349 Celanire (10.1124/jpet.114.222463_bib21) 2015; 25 Hunter (10.1124/jpet.114.222463_bib51) 1997; 324 Kim (10.1124/jpet.114.222463_bib44) 1992; 50 Lindemann (10.1124/jpet.114.222463_bib64) 2011; 339 Moreau (10.1124/jpet.114.222463_bib76) 2002; 4 Piers (10.1124/jpet.114.222463_bib88) 2012; 3 Paxinos (10.1124/jpet.114.222463_bib84) 1986 Krystal (10.1124/jpet.114.222463_bib58) 2013; 73 Bennett (10.1124/jpet.114.222463_bib13) 1988; 33 Hughes (10.1124/jpet.114.222463_bib50) 2013; 66 Nestler (10.1124/jpet.114.222463_bib81) 2002; 34 Rowley (10.1124/jpet.114.222463_bib95) 2014; 28 Marek (10.1124/jpet.114.222463_bib68) 2010; 639 Lopes (10.1124/jpet.114.222463_bib66) 2013; 110 Kupfer (10.1124/jpet.114.222463_bib60) 2012; 379 Fitch (10.1124/jpet.114.222463_bib31) 2010; 4 Hill (10.1124/jpet.114.222463_bib42) 2012; 36 Jaeschke (10.1124/jpet.114.222463_bib54) 2008; 18 Cavas (10.1124/jpet.114.222463_bib20) 2013; 40 Masu (10.1124/jpet.114.222463_bib69) 1991; 349 O’Donnel (10.1124/jpet.114.222463_bib83) 2011 Morairty (10.1124/jpet.114.222463_bib75) 2008; 31 Basile (10.1124/jpet.114.222463_bib10) 2007; 321 Michalon (10.1124/jpet.114.222463_bib72) 2012; 74 Duman (10.1124/jpet.114.222463_bib30) 2014; 31 Gasparini (10.1124/jpet.114.222463_bib33) 2008; 11 Radulovic (10.1124/jpet.114.222463_bib94) 2012; 15 Cryan (10.1124/jpet.114.222463_bib25) 2000; 295 Valles (10.1124/jpet.114.222463_bib109) 1995; 23 Williams (10.1124/jpet.114.222463_bib112) 1972; 28 Tokunaga (10.1124/jpet.114.222463_bib107) 2009; 29 Moreau (10.1124/jpet.114.222463_bib77) 1996; 6 Zarate (10.1124/jpet.114.222463_bib115) 2006; 63 Gasparini (10.1124/jpet.114.222463_bib34) 1999; 38 Michalon (10.1124/jpet.114.222463_bib71) 2014; 75 Dang (10.1124/jpet.114.222463_bib26) 2002; 136 Albertini (10.1124/jpet.114.222463_bib3) 1988; 12 Ballard (10.1124/jpet.114.222463_bib9) 2005; 179 Petrov (10.1124/jpet.114.222463_bib87) 2014; 23 Beitinger (10.1124/jpet.114.222463_bib12) 2010 Bruns (10.1124/jpet.114.222463_bib17) 2009; 61 Tobler (10.1124/jpet.114.222463_bib106) 1986; 64 Hamon (10.1124/jpet.114.222463_bib38) 2013; 45 Hu (10.1124/jpet.114.222463_bib49) 2009; 450 Cosford (10.1124/jpet.114.222463_bib22) 2003; 46 Hysek (10.1124/jpet.114.222463_bib52) 2012; 7 Porsolt (10.1124/jpet.114.222463_bib91) 1978; 47 Blok (10.1124/jpet.114.222463_bib15) 2002; 59 Borbély (10.1124/jpet.114.222463_bib16) 2011; 98 Goeldner (10.1124/jpet.114.222463_bib35) 2013; 64 Pecknold (10.1124/jpet.114.222463_bib85) 1982; 2 Covington (10.1124/jpet.114.222463_bib23) 2010; 58 Moreau (10.1124/jpet.114.222463_bib78) 1992; 2 Higgins (10.1124/jpet.114.222463_bib41) 2004; 46 Hu (10.1124/jpet.114.222463_bib48) 2012; 15 Staner (10.1124/jpet.114.222463_bib103) 2010 10.1124/jpet.114.222463_bib18 Kuwajima (10.1124/jpet.114.222463_bib61) 2004; 474 Seese (10.1124/jpet.114.222463_bib99) 2014; 39 Petersen (10.1124/jpet.114.222463_bib86) 2002; 73 Dharmshaktu (10.1124/jpet.114.222463_bib28) 2012; 52 Grippo (10.1124/jpet.114.222463_bib36) 2005; 84 Kakizaki (10.1124/jpet.114.222463_bib55) 1998; 285 Hintermann (10.1124/jpet.114.222463_bib43) 2007; 15 |
| References_xml | – volume: 43 start-page: 181 year: 2002 end-page: 187 ident: bib89 article-title: Multiple MPEP administrations evoke anxiolytic- and antidepressant-like effects in rats publication-title: Neuropharmacology – volume: 15 start-page: 805 year: 2012 end-page: 807 ident: bib94 article-title: Preso1, mGluR5 and the machinery of pain publication-title: Nat Neurosci – volume: 252 start-page: 1318 year: 1991 end-page: 1321 ident: bib46 article-title: Cloning, expression, and gene structure of a G protein-coupled glutamate receptor from rat brain publication-title: Science – volume: 897 start-page: 171 year: 2012 end-page: 180 ident: bib11 article-title: Characterization of G-protein coupled receptor modulators using homogeneous cAMP assays publication-title: Methods Mol Biol – volume: 63 start-page: 123 year: 2011 end-page: 133 ident: bib32 article-title: A pharmacokinetic-pharmacodynamic model for cardiovascular safety assessment of R1551 publication-title: J Pharmacol Toxicol Methods – volume: 2 start-page: 43 year: 1992 end-page: 49 ident: bib78 article-title: Antidepressant treatment prevents chronic unpredictable mild stress-induced anhedonia as assessed by ventral tegmentum self-stimulation behavior in rats publication-title: Eur Neuropsychopharmacol – volume: 14 start-page: 609 year: 2013 end-page: 625 ident: bib96 article-title: The brain reward circuitry in mood disorders publication-title: Nat Rev Neurosci – volume: 15 start-page: 836 year: 2012 end-page: 844 ident: bib48 article-title: Preso1 dynamically regulates group I metabotropic glutamate receptors publication-title: Nat Neurosci – volume: 18 start-page: 321 year: 2003 end-page: 329 ident: bib80 article-title: Structure-activity relationship of oxadiazoles and allylic structures in the Ames test: an industry screening approach publication-title: Mutagenesis – volume: 450 start-page: 12 year: 2009 end-page: 17 ident: bib49 article-title: The role of metabotropic glutamate receptor mGlu5 in control of micturition and bladder nociception publication-title: Neurosci Lett – start-page: 202 year: 2010 end-page: 221 ident: bib103 article-title: Antidepressant-induced alteration of sleep EEG publication-title: Sleep and Mental Illness – volume: 48 start-page: 247 year: 2007 end-page: 252 ident: bib7 article-title: Human PET studies of metabotropic glutamate receptor subtype 5 with 11C-ABP688 publication-title: J Nucl Med – volume: 65 start-page: 1611 year: 2013 end-page: 1621 ident: bib73 article-title: Neuronal and immunological basis of action of antidepressants in chronic pain—clinical and experimental studies publication-title: Pharmacol Rep – volume: 8 start-page: 20 year: 2012 ident: bib24 article-title: Metabotropic glutamate receptor 5 (mGluR5) regulates bladder nociception publication-title: Mol Pain – reference: DOI: 10.1007/s00213-014-3746-4 [published ahead of print]. – volume: 435 start-page: 161 year: 2002 end-page: 170 ident: bib102 article-title: Pharmacological and endocrinological characterisation of stress-induced hyperthermia in singly housed mice using classical and candidate anxiolytics (LY314582, MPEP and NKP608) publication-title: Eur J Pharmacol – volume: 15 start-page: 903 year: 2007 end-page: 914 ident: bib43 article-title: ABP688, a novel selective and high affinity ligand for the labeling of mGlu5 receptors: identification, in vitro pharmacology, pharmacokinetic and biodistribution studies publication-title: Bioorg Med Chem – volume: 23 start-page: 1051 year: 1995 end-page: 1057 ident: bib109 article-title: Metabolism of mofarotene in hepatocytes and liver microsomes from different species. Comparison with in vivo data and evaluation of the cytochrome P450 isoenzymes involved in human biotransformation publication-title: Drug Metab Dispos – volume: 46 start-page: 204 year: 2003 end-page: 206 ident: bib22 article-title: 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity publication-title: J Med Chem – volume: 18 start-page: 123 year: 2008 end-page: 142 ident: bib54 article-title: mGlu5 receptor antagonists and their therapeutic potential publication-title: Expert Opin Ther Patients – reference: Buettelmann B, Ceccarelli SM, Jaeschke G, Kolczewski S, Porter RHP, Vieira E, Ford APDW, and Zhong Y (2005), inventors, F. Hoffmann-La Roche AG, assignee. Imidazole derivatives. U.S. patent 11/020,451 US20050143375 A1. 2005 Jun 30. – volume: 4 start-page: 77 year: 2010 end-page: 87 ident: bib31 article-title: Application of modern drug metabolism structure determination tools and assays to the in vitro metabolism of imiloxan publication-title: Drug Metab Lett – volume: 213 start-page: 533 year: 2011 end-page: 541 ident: bib37 article-title: FLASH imaging: rapid NMR imaging using low flip-angle pulses. 1986 publication-title: J Magn Reson – volume: 74 start-page: 49 year: 2012 end-page: 56 ident: bib72 article-title: Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice publication-title: Neuron – volume: 639 start-page: 81 year: 2010 end-page: 90 ident: bib68 article-title: Metabotropic glutamate2/3 (mGlu2/3) receptors, schizophrenia and cognition publication-title: Eur J Pharmacol – volume: 4 start-page: 351 year: 2002 end-page: 360 ident: bib76 article-title: Simulating the anhedonia symptom of depression in animals publication-title: Dialogues Clin Neurosci – volume: 73 start-page: 381 year: 2002 end-page: 389 ident: bib86 article-title: Differential effects of mGluR1 and mGlur5 antagonism on spatial learning in rats publication-title: Pharmacol Biochem Behav – volume: 17 start-page: 2106 year: 2003 end-page: 2118 ident: bib8 article-title: Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: opposite regulation of glutamate transporter proteins publication-title: Eur J Neurosci – volume: 3 start-page: 823 year: 1986 end-page: 833 ident: bib40 article-title: RARE imaging: a fast imaging method for clinical MR publication-title: Magn Reson Med – volume: 102 start-page: 64 year: 2012 end-page: 71 ident: bib47 article-title: Blockade of metabotropic glutamate receptors inhibits cognition and neurodegeneration in an MPTP-induced Parkinson’s disease rat model publication-title: Pharmacol Biochem Behav – volume: 13 start-page: 219 year: 1997 end-page: 241 ident: bib67 article-title: Differential plasma membrane distribution of metabotropic glutamate receptors mGluR1 alpha, mGluR2 and mGluR5, relative to neurotransmitter release sites publication-title: J Chem Neuroanat – year: 1986 ident: bib84 publication-title: The Rat Brain in Stereotaxic Coordinates – volume: 98 start-page: 205 year: 2011 end-page: 213 ident: bib16 article-title: Manifestations and functional implications of sleep homeostasis publication-title: Handb Clin Neurol – volume: 46 start-page: 907 year: 2004 end-page: 917 ident: bib41 article-title: Pharmacological manipulation of mGlu2 receptors influences cognitive performance in the rodent publication-title: Neuropharmacology – volume: 38 start-page: 1493 year: 1999 end-page: 1503 ident: bib34 article-title: 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist publication-title: Neuropharmacology – volume: 321 start-page: 1208 year: 2007 end-page: 1225 ident: bib10 article-title: Characterization of the antinociceptive actions of bicifadine in models of acute, persistent, and chronic pain publication-title: J Pharmacol Exp Ther – volume: 28 start-page: 633 year: 1997 end-page: 638 ident: bib29 article-title: The pharmacology of excitatory and inhibitory amino acid-mediated events in the transmission and modulation of pain in the spinal cord publication-title: Gen Pharmacol – volume: 179 start-page: 218 year: 2005 end-page: 229 ident: bib9 article-title: The effect of the mGlu5 receptor antagonist MPEP in rodent tests of anxiety and cognition: a comparison publication-title: Psychopharmacology (Berl) – start-page: 183 year: 2010 end-page: 201 ident: bib12 article-title: Long-term effects of antidepressants on sleep publication-title: Sleep and Mental Illness – volume: 7 start-page: e36476 year: 2012 ident: bib52 article-title: Duloxetine inhibits effects of MDMA (“ecstasy”) in vitro and in humans in a randomized placebo-controlled laboratory study publication-title: PLoS ONE – volume: 474 start-page: 589 year: 2004 end-page: 602 ident: bib61 article-title: Subcellular and subsynaptic localization of group I metabotropic glutamate receptors in the monkey subthalamic nucleus publication-title: J Comp Neurol – volume: 45 start-page: 54 year: 2013 end-page: 63 ident: bib38 article-title: Monoamine neurocircuitry in depression and strategies for new treatments publication-title: Prog Neuropsychopharmacol Biol Psychiatry – volume: 29 start-page: 1971 year: 2004 end-page: 1979 ident: bib19 article-title: The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in rodent models of anxiety publication-title: Neuropsychopharmacology – volume: 168 start-page: 114 year: 2011 end-page: 116 ident: bib74 article-title: Toward neurotrophin-based therapeutics publication-title: Am J Psychiatry – volume: 295 start-page: 1120 year: 2000 end-page: 1126 ident: bib25 article-title: Antidepressant-like behavioral effects mediated by 5-hydroxytryptamine(2C) receptors publication-title: J Pharmacol Exp Ther – volume: 73 start-page: 1133 year: 2013 end-page: 1141 ident: bib58 article-title: Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond publication-title: Biol Psychiatry – volume: 31 start-page: 291 year: 2014 end-page: 296 ident: bib30 article-title: Neurobiology of stress, depression, and rapid acting antidepressants: remodeling synaptic connections publication-title: Depress Anxiety – volume: 11 start-page: 655 year: 2008 end-page: 665 ident: bib33 article-title: mGluR5 antagonists: discovery, characterization and drug development publication-title: Curr Opin Drug Discov Devel – volume: 63 start-page: 856 year: 2006 end-page: 864 ident: bib115 article-title: A randomized trial of an publication-title: Arch Gen Psychiatry – volume: 33 start-page: 87 year: 1988 end-page: 107 ident: bib13 article-title: A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man publication-title: Pain – volume: 16 start-page: 1236 year: 1996 end-page: 1249 ident: bib4 article-title: Reduced transit-time sensitivity in noninvasive magnetic resonance imaging of human cerebral blood flow publication-title: J Cereb Blood Flow Metab – volume: 84 start-page: 697 year: 2005 end-page: 706 ident: bib36 article-title: Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia publication-title: Physiol Behav – volume: 20C start-page: 124 year: 2015 end-page: 134 ident: bib98 article-title: Metabotropic glutamate receptor 5 as drug target for Fragile X syndrome publication-title: Curr Opin Pharmacol – volume: 58 start-page: 683 year: 2010 end-page: 693 ident: bib23 article-title: From synapse to nucleus: novel targets for treating depression publication-title: Neuropharmacology – volume: 319 start-page: 254 year: 2006 end-page: 259 ident: bib63 article-title: Metabotropic glutamate 5 receptor antagonism is associated with antidepressant-like effects in mice publication-title: J Pharmacol Exp Ther – volume: 3 start-page: 199 year: 2012 ident: bib88 article-title: Translational Concepts of mGluR5 in Synaptic Diseases of the Brain publication-title: Front Pharmacol – volume: 28 start-page: 254 year: 2014 end-page: 269 ident: bib95 article-title: Differences in the neurochemical and behavioural profiles of lisdexamfetamine methylphenidate and modafinil revealed by simultaneous dual-probe microdialysis and locomotor activity measurements in freely-moving rats publication-title: J Psychopharmacol – volume: 75 start-page: 19 year: 2013 end-page: 30 ident: bib39 article-title: Neurophysiological signals as potential translatable biomarkers for modulation of metabotropic glutamate 5 receptors publication-title: Neuropharmacology – volume: 39 start-page: 1664 year: 2014 end-page: 1673 ident: bib99 article-title: Long-term memory deficits are associated with elevated synaptic ERK1/2 activation and reversed by mGluR5 antagonism in an animal model of autism publication-title: Neuropsychopharmacology – volume: 379 start-page: 1045 year: 2012 end-page: 1055 ident: bib60 article-title: Major depressive disorder: new clinical, neurobiological, and treatment perspectives publication-title: Lancet – volume: 589 start-page: 5833 year: 2011 end-page: 5843 ident: bib62 article-title: Involvement of metabotropic glutamate receptor 5 in pudendal inhibition of nociceptive bladder activity in cats publication-title: J Physiol – volume: 349 start-page: 155 year: 2014 end-page: 164 ident: bib105 article-title: mGluR5 antagonist-induced psychoactive properties: MTEP drug discrimination, a pharmacologically selective non-NMDA effect with apparent lack of reinforcing properties publication-title: J Pharmacol Exp Ther – volume: 24 start-page: S468 year: 2014 ident: bib93 article-title: P.2.f.027 The efficacy and safety of basimglurant as adjunctive therapy in major depression; a randomised, double-blind, placebo-controlled study (Abstract) publication-title: Eur Neuropsychopharmacol – volume: 89 start-page: 212 year: 1992 end-page: 216 ident: bib113 article-title: Magnetic resonance imaging of perfusion using spin inversion of arterial water publication-title: Proc Natl Acad Sci USA – volume: 61 start-page: 1451 year: 2009 end-page: 1458 ident: bib17 article-title: Validation of cerebral blood perfusion imaging as a modality for quantitative pharmacological MRI in rats publication-title: Magn Reson Med – volume: 285 start-page: 22 year: 1998 end-page: 27 ident: bib55 article-title: Role of spinal glutamatergic transmission in the ascending limb of the micturition reflex pathway in the rat publication-title: J Pharmacol Exp Ther – volume: 36 start-page: 2085 year: 2012 end-page: 2117 ident: bib42 article-title: Neurobiology of chronic mild stress: parallels to major depression publication-title: Neurosci Biobehav Rev – volume: 219 start-page: 354 year: 2011 end-page: 357 ident: bib108 article-title: The effects of the mGluR5 receptor antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP) on the stimulation of dopamine release evoked by nicotine in the rat brain publication-title: Behav Brain Res – volume: 29 start-page: 1887 year: 2009 end-page: 1896 ident: bib107 article-title: Neuroimaging and physiological evidence for involvement of glutamatergic transmission in regulation of the striatal dopaminergic system publication-title: J Neurosci – volume: 28 start-page: 1838 year: 2013 end-page: 1846 ident: bib104 article-title: AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study publication-title: Mov Disord – reference: Jaeschke G, Kolczewski S, Spooren W, Vieira E, Bitter-Stoll N, Boissin P, Borroni E, Buttelmann B, Ceccarelli S, Clemann N, et al. (2015) Metabotropic glutamate receptor 5 negative allosteric modulators: discovery of 2-chloro-4-[1-(4-fluorophenyl)-2,5-dimethyl-1 – volume: 23 start-page: 1165 year: 2014 end-page: 1179 ident: bib87 article-title: Mavoglurant as a treatment for Parkinson’s disease publication-title: Expert Opin Investig Drugs – volume: 219 start-page: 271 year: 2012 end-page: 279 ident: bib59 article-title: Transient mGlu5R inhibition enhances the survival of granule cell precursors in the neonatal cerebellum publication-title: Neuroscience – volume: 339 start-page: 474 year: 2011 end-page: 486 ident: bib64 article-title: CTEP: a novel, potent, long-acting, and orally bioavailable metabotropic glutamate receptor 5 inhibitor publication-title: J Pharmacol Exp Ther – volume: 34 start-page: 13 year: 2002 end-page: 25 ident: bib81 article-title: Neurobiology of depression publication-title: Neuron – volume: 2 start-page: 129 year: 1982 end-page: 133 ident: bib85 article-title: Treatment of anxiety using fenobam (a nonbenzodiazepine) in a double-blind standard (diazepam) placebo-controlled study publication-title: J Clin Psychopharmacol – volume: 62 start-page: 411 year: 2011 end-page: 429 ident: bib57 article-title: Toward fulfilling the promise of molecular medicine in fragile X syndrome publication-title: Annu Rev Med – year: 2000 ident: bib5 publication-title: Diagnostic and Statistical Manual of Mental Disorders – volume: 42 start-page: 206 year: 1999 end-page: 209 ident: bib27 article-title: Fast T1 mapping on a whole-body scanner publication-title: Magn Reson Med – volume: 6 start-page: 682 year: 1995 end-page: 687 ident: bib79 article-title: Chronic mild stress-induced anhedonia model of depression; sleep abnormalities and curative effects of electroshock treatment publication-title: Behav Pharmacol – volume: 47 start-page: 698 year: 2006 end-page: 705 ident: bib6 article-title: Radiosynthesis and preclinical evaluation of 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5 publication-title: J Nucl Med – volume: 47 start-page: 379 year: 1978 end-page: 391 ident: bib91 article-title: Behavioural despair in rats: a new model sensitive to antidepressant treatments publication-title: Eur J Pharmacol – volume: 6 start-page: 169 year: 1996 end-page: 175 ident: bib77 article-title: 5HT2C receptor agonists exhibit antidepressant-like properties in the anhedonia model of depression in rats publication-title: Eur Neuropsychopharmacol – volume: 31 start-page: 34 year: 2008 end-page: 44 ident: bib75 article-title: Selective 5HT2A and 5HT6 receptor antagonists promote sleep in rats publication-title: Sleep – volume: 13 start-page: 1161 year: 2010 end-page: 1169 ident: bib82 article-title: Animal models of neuropsychiatric disorders publication-title: Nat Neurosci – start-page: 63 year: 2000 end-page: 98 ident: bib100 article-title: Metabotropic glutamate receptors—immunocytochemical and in situ hybridization analyses publication-title: Handbook of Chemical Neuroanatomy: Glutamate – reference: -imidazol-4-ylethynyl]pyridine (basimglurant, RO4917523), a promising novel medicine for psychiatric diseases. – reference: DOI: 10.1021/jm501642c [published ahead of print]. – volume: 64 start-page: 337 year: 2013 end-page: 346 ident: bib35 article-title: Cognitive impairment in major depression and the mGlu2 receptor as a therapeutic target publication-title: Neuropharmacology – volume: 62 start-page: 92 year: 2007 end-page: 100 ident: bib45 article-title: Enhanced long-term synaptic depression in an animal model of depression publication-title: Biol Psychiatry – volume: 349 start-page: 760 year: 1991 end-page: 765 ident: bib69 article-title: Sequence and expression of a metabotropic glutamate receptor publication-title: Nature – volume: 52 start-page: 6 year: 2012 end-page: 17 ident: bib28 article-title: Efficacy of antidepressants as analgesics: a review publication-title: J Clin Pharmacol – volume: 324 start-page: 153 year: 1997 end-page: 160 ident: bib51 article-title: The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain publication-title: Eur J Pharmacol – volume: 315 start-page: 711 year: 2005 end-page: 721 ident: bib92 article-title: Fenobam: a clinically validated nonbenzodiazepine anxiolytic is a potent, selective, and noncompetitive mGlu5 receptor antagonist with inverse agonist activity publication-title: J Pharmacol Exp Ther – start-page: 397 year: 2011 end-page: 416 ident: bib83 article-title: Drug therapy of depression and anxiety disorders publication-title: Goodman and Gilman’s The Pharmacological Basis of Therapeutics – volume: 64 start-page: 74 year: 1986 end-page: 76 ident: bib106 article-title: Sleep EEG in the rat as a function of prior waking publication-title: Electroencephalogr Clin Neurophysiol – volume: 59 start-page: 13 year: 2002 end-page: 17 ident: bib15 article-title: Central pathways controlling micturition and urinary continence publication-title: Urology – volume: 110 start-page: 19 year: 2013 end-page: 26 ident: bib66 article-title: Peripheral antinociceptive action of mangiferin in mouse models of experimental pain: role of endogenous opioids, K(ATP)-channels and adenosine publication-title: Pharmacol Biochem Behav – volume: 27 start-page: 103 year: 1971 end-page: 117 ident: bib111 article-title: A test for differences between treatment means when several dose levels are compared with a zero dose control publication-title: Biometrics – reference: Ahnaou A, Langlois X, Steckler T, Bartolome-Nebreda JM, Drinkenburg WH (2014) Negative versus positive allosteric modulation of metabotropic glutamate receptors (mGluR5): indices for potential pro-cognitive drug properties based on EEG network oscillations and sleep-wake organization in rats. – volume: 25 start-page: 69 year: 2015 end-page: 90 ident: bib21 article-title: Novel metabotropic glutamate receptor 2/3 antagonists and their therapeutic applications: a patent review (2005–present) publication-title: Expert Opin Ther Pat – volume: 62 start-page: 63 year: 2012 end-page: 77 ident: bib97 article-title: Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders publication-title: Neuropharmacology – volume: 702 start-page: 193 year: 2010 end-page: 198 ident: bib56 article-title: Comparison of different cytotoxicity measures for the in vitro micronucleus test (MNVit) in L5178Y tk(+/−) cells: summary of 4 compounds (mitomycin C, cyclophosphamide, colchicine and diethylstilboestrol) with clastogenic and aneugenic mode of action publication-title: Mutat Res – volume: 136 start-page: 248 year: 2002 end-page: 254 ident: bib26 article-title: Interaction of group I mGlu and NMDA receptor agonists within the dorsal horn of the spinal cord of the juvenile rat publication-title: Br J Pharmacol – volume: 50 start-page: 355 year: 1992 end-page: 363 ident: bib44 article-title: An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat publication-title: Pain – volume: 179 start-page: 292 year: 2005 end-page: 302 ident: bib101 article-title: Effects of the mGluR2/3 agonist LY354740 on computerized tasks of attention and working memory in marmoset monkeys publication-title: Psychopharmacology (Berl) – volume: 40 start-page: 18 year: 2013 end-page: 25 ident: bib20 article-title: Effects of MPEP, a selective metabotropic glutamate mGlu5 ligand, on sleep and wakefulness in the rat publication-title: Prog Neuropsychopharmacol Biol Psychiatry – volume: 20 start-page: 533 year: 2005 end-page: 559 ident: bib70 article-title: Antidepressants and their effect on sleep publication-title: Hum Psychopharmacol – volume: 223 start-page: 219 year: 2012 end-page: 224 ident: bib65 article-title: Metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine produces antidepressant effects in rats: role of brain-derived neurotrophic factor publication-title: Neuroscience – volume: 22 start-page: 5790 year: 2014 end-page: 5803 ident: bib110 article-title: AFQ056/mavoglurant, a novel clinically effective mGluR5 antagonist: identification, SAR and pharmacological characterization publication-title: Bioorg Med Chem – volume: 159 start-page: 250 year: 1999 end-page: 257 ident: bib114 article-title: Influence of glutamate receptor antagonists on micturition in rats with spinal cord injury publication-title: Exp Neurol – start-page: 361 year: 2010 end-page: 390 ident: bib14 article-title: Antidepressant treatment in anxiety disorder publication-title: Behavioral Neurobiology of Anxiety and Its Treatment – volume: 75 start-page: 189 year: 2014 end-page: 197 ident: bib71 article-title: Chronic metabotropic glutamate receptor 5 inhibition corrects local alterations of brain activity and improves cognitive performance in fragile X mice publication-title: Biol Psychiatry – volume: 66 start-page: 202 year: 2013 end-page: 214 ident: bib50 article-title: Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depression publication-title: Neuropharmacology – volume: 200 start-page: 167 year: 2008 end-page: 176 ident: bib90 article-title: Attenuation of cocaine self-administration in squirrel monkeys following repeated administration of the mGluR5 antagonist MPEP: comparison with dizocilpine publication-title: Psychopharmacology (Berl) – start-page: 165 year: 2010 end-page: 172 ident: bib1 article-title: The association between sleep disorders and depression: implications for treatment publication-title: Sleep and Mental Illness – volume: 28 start-page: 519 year: 1972 end-page: 531 ident: bib112 article-title: The comparison of several dose levels with a zero dose control publication-title: Biometrics – volume: 12 start-page: 353 year: 1988 end-page: 363 ident: bib3 article-title: Plasmid copy number and mutant frequencies in S. typhimurium TA102 publication-title: Environ Mol Mutagen – volume: 33 start-page: 87 year: 1988 ident: 10.1124/jpet.114.222463_bib13 article-title: A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man publication-title: Pain doi: 10.1016/0304-3959(88)90209-6 – volume: 29 start-page: 1971 year: 2004 ident: 10.1124/jpet.114.222463_bib19 article-title: The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in rodent models of anxiety publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300540 – volume: 339 start-page: 474 year: 2011 ident: 10.1124/jpet.114.222463_bib64 article-title: CTEP: a novel, potent, long-acting, and orally bioavailable metabotropic glutamate receptor 5 inhibitor publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.111.185660 – volume: 73 start-page: 1133 year: 2013 ident: 10.1124/jpet.114.222463_bib58 article-title: Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2013.03.026 – volume: 89 start-page: 212 year: 1992 ident: 10.1124/jpet.114.222463_bib113 article-title: Magnetic resonance imaging of perfusion using spin inversion of arterial water publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.89.1.212 – year: 2000 ident: 10.1124/jpet.114.222463_bib5 – volume: 702 start-page: 193 year: 2010 ident: 10.1124/jpet.114.222463_bib56 article-title: Comparison of different cytotoxicity measures for the in vitro micronucleus test (MNVit) in L5178Y tk(+/−) cells: summary of 4 compounds (mitomycin C, cyclophosphamide, colchicine and diethylstilboestrol) with clastogenic and aneugenic mode of action publication-title: Mutat Res doi: 10.1016/j.mrgentox.2010.03.018 – start-page: 361 year: 2010 ident: 10.1124/jpet.114.222463_bib14 article-title: Antidepressant treatment in anxiety disorder – volume: 136 start-page: 248 year: 2002 ident: 10.1124/jpet.114.222463_bib26 article-title: Interaction of group I mGlu and NMDA receptor agonists within the dorsal horn of the spinal cord of the juvenile rat publication-title: Br J Pharmacol doi: 10.1038/sj.bjp.0704698 – volume: 12 start-page: 353 year: 1988 ident: 10.1124/jpet.114.222463_bib3 article-title: Plasmid copy number and mutant frequencies in S. typhimurium TA102 publication-title: Environ Mol Mutagen doi: 10.1002/em.2860120404 – start-page: 63 year: 2000 ident: 10.1124/jpet.114.222463_bib100 article-title: Metabotropic glutamate receptors—immunocytochemical and in situ hybridization analyses doi: 10.1016/S0924-8196(00)80044-5 – ident: 10.1124/jpet.114.222463_bib18 – volume: 47 start-page: 379 year: 1978 ident: 10.1124/jpet.114.222463_bib91 article-title: Behavioural despair in rats: a new model sensitive to antidepressant treatments publication-title: Eur J Pharmacol doi: 10.1016/0014-2999(78)90118-8 – volume: 84 start-page: 697 year: 2005 ident: 10.1124/jpet.114.222463_bib36 article-title: Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia publication-title: Physiol Behav doi: 10.1016/j.physbeh.2005.02.011 – volume: 349 start-page: 760 year: 1991 ident: 10.1124/jpet.114.222463_bib69 article-title: Sequence and expression of a metabotropic glutamate receptor publication-title: Nature doi: 10.1038/349760a0 – volume: 15 start-page: 903 year: 2007 ident: 10.1124/jpet.114.222463_bib43 article-title: ABP688, a novel selective and high affinity ligand for the labeling of mGlu5 receptors: identification, in vitro pharmacology, pharmacokinetic and biodistribution studies publication-title: Bioorg Med Chem doi: 10.1016/j.bmc.2006.10.038 – volume: 7 start-page: e36476 year: 2012 ident: 10.1124/jpet.114.222463_bib52 article-title: Duloxetine inhibits effects of MDMA (“ecstasy”) in vitro and in humans in a randomized placebo-controlled laboratory study publication-title: PLoS ONE doi: 10.1371/journal.pone.0036476 – start-page: 202 year: 2010 ident: 10.1124/jpet.114.222463_bib103 article-title: Antidepressant-induced alteration of sleep EEG – volume: 42 start-page: 206 year: 1999 ident: 10.1124/jpet.114.222463_bib27 article-title: Fast T1 mapping on a whole-body scanner publication-title: Magn Reson Med doi: 10.1002/(SICI)1522-2594(199907)42:1<206::AID-MRM28>3.0.CO;2-Q – volume: 324 start-page: 153 year: 1997 ident: 10.1124/jpet.114.222463_bib51 article-title: The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain publication-title: Eur J Pharmacol doi: 10.1016/S0014-2999(97)00070-8 – volume: 589 start-page: 5833 year: 2011 ident: 10.1124/jpet.114.222463_bib62 article-title: Involvement of metabotropic glutamate receptor 5 in pudendal inhibition of nociceptive bladder activity in cats publication-title: J Physiol doi: 10.1113/jphysiol.2011.215657 – volume: 252 start-page: 1318 year: 1991 ident: 10.1124/jpet.114.222463_bib46 article-title: Cloning, expression, and gene structure of a G protein-coupled glutamate receptor from rat brain publication-title: Science doi: 10.1126/science.1656524 – volume: 31 start-page: 291 year: 2014 ident: 10.1124/jpet.114.222463_bib30 article-title: Neurobiology of stress, depression, and rapid acting antidepressants: remodeling synaptic connections publication-title: Depress Anxiety doi: 10.1002/da.22227 – volume: 219 start-page: 354 year: 2011 ident: 10.1124/jpet.114.222463_bib108 article-title: The effects of the mGluR5 receptor antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP) on the stimulation of dopamine release evoked by nicotine in the rat brain publication-title: Behav Brain Res doi: 10.1016/j.bbr.2010.12.024 – volume: 25 start-page: 69 year: 2015 ident: 10.1124/jpet.114.222463_bib21 article-title: Novel metabotropic glutamate receptor 2/3 antagonists and their therapeutic applications: a patent review (2005–present) publication-title: Expert Opin Ther Pat doi: 10.1517/13543776.2014.983899 – volume: 4 start-page: 77 year: 2010 ident: 10.1124/jpet.114.222463_bib31 article-title: Application of modern drug metabolism structure determination tools and assays to the in vitro metabolism of imiloxan publication-title: Drug Metab Lett doi: 10.2174/187231210791292753 – volume: 28 start-page: 519 year: 1972 ident: 10.1124/jpet.114.222463_bib112 article-title: The comparison of several dose levels with a zero dose control publication-title: Biometrics doi: 10.2307/2556164 – volume: 20 start-page: 533 year: 2005 ident: 10.1124/jpet.114.222463_bib70 article-title: Antidepressants and their effect on sleep publication-title: Hum Psychopharmacol doi: 10.1002/hup.726 – volume: 13 start-page: 1161 year: 2010 ident: 10.1124/jpet.114.222463_bib82 article-title: Animal models of neuropsychiatric disorders publication-title: Nat Neurosci doi: 10.1038/nn.2647 – volume: 2 start-page: 43 year: 1992 ident: 10.1124/jpet.114.222463_bib78 article-title: Antidepressant treatment prevents chronic unpredictable mild stress-induced anhedonia as assessed by ventral tegmentum self-stimulation behavior in rats publication-title: Eur Neuropsychopharmacol doi: 10.1016/0924-977X(92)90035-7 – volume: 63 start-page: 123 year: 2011 ident: 10.1124/jpet.114.222463_bib32 article-title: A pharmacokinetic-pharmacodynamic model for cardiovascular safety assessment of R1551 publication-title: J Pharmacol Toxicol Methods doi: 10.1016/j.vascn.2010.08.003 – volume: 29 start-page: 1887 year: 2009 ident: 10.1124/jpet.114.222463_bib107 article-title: Neuroimaging and physiological evidence for involvement of glutamatergic transmission in regulation of the striatal dopaminergic system publication-title: J Neurosci doi: 10.1523/JNEUROSCI.2559-08.2009 – volume: 64 start-page: 337 year: 2013 ident: 10.1124/jpet.114.222463_bib35 article-title: Cognitive impairment in major depression and the mGlu2 receptor as a therapeutic target publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2012.08.001 – volume: 27 start-page: 103 year: 1971 ident: 10.1124/jpet.114.222463_bib111 article-title: A test for differences between treatment means when several dose levels are compared with a zero dose control publication-title: Biometrics doi: 10.2307/2528930 – volume: 159 start-page: 250 year: 1999 ident: 10.1124/jpet.114.222463_bib114 article-title: Influence of glutamate receptor antagonists on micturition in rats with spinal cord injury publication-title: Exp Neurol doi: 10.1006/exnr.1999.7124 – volume: 639 start-page: 81 year: 2010 ident: 10.1124/jpet.114.222463_bib68 article-title: Metabotropic glutamate2/3 (mGlu2/3) receptors, schizophrenia and cognition publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2010.02.058 – volume: 22 start-page: 5790 year: 2014 ident: 10.1124/jpet.114.222463_bib110 article-title: AFQ056/mavoglurant, a novel clinically effective mGluR5 antagonist: identification, SAR and pharmacological characterization publication-title: Bioorg Med Chem doi: 10.1016/j.bmc.2014.09.033 – volume: 200 start-page: 167 year: 2008 ident: 10.1124/jpet.114.222463_bib90 article-title: Attenuation of cocaine self-administration in squirrel monkeys following repeated administration of the mGluR5 antagonist MPEP: comparison with dizocilpine publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-008-1191-y – volume: 48 start-page: 247 year: 2007 ident: 10.1124/jpet.114.222463_bib7 article-title: Human PET studies of metabotropic glutamate receptor subtype 5 with 11C-ABP688 publication-title: J Nucl Med – volume: 64 start-page: 74 year: 1986 ident: 10.1124/jpet.114.222463_bib106 article-title: Sleep EEG in the rat as a function of prior waking publication-title: Electroencephalogr Clin Neurophysiol doi: 10.1016/0013-4694(86)90044-1 – volume: 36 start-page: 2085 year: 2012 ident: 10.1124/jpet.114.222463_bib42 article-title: Neurobiology of chronic mild stress: parallels to major depression publication-title: Neurosci Biobehav Rev doi: 10.1016/j.neubiorev.2012.07.001 – volume: 17 start-page: 2106 year: 2003 ident: 10.1124/jpet.114.222463_bib8 article-title: Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: opposite regulation of glutamate transporter proteins publication-title: Eur J Neurosci doi: 10.1046/j.1460-9568.2003.02657.x – volume: 474 start-page: 589 year: 2004 ident: 10.1124/jpet.114.222463_bib61 article-title: Subcellular and subsynaptic localization of group I metabotropic glutamate receptors in the monkey subthalamic nucleus publication-title: J Comp Neurol doi: 10.1002/cne.20158 – volume: 23 start-page: 1165 year: 2014 ident: 10.1124/jpet.114.222463_bib87 article-title: Mavoglurant as a treatment for Parkinson’s disease publication-title: Expert Opin Investig Drugs doi: 10.1517/13543784.2014.931370 – volume: 28 start-page: 254 year: 2014 ident: 10.1124/jpet.114.222463_bib95 article-title: Differences in the neurochemical and behavioural profiles of lisdexamfetamine methylphenidate and modafinil revealed by simultaneous dual-probe microdialysis and locomotor activity measurements in freely-moving rats publication-title: J Psychopharmacol doi: 10.1177/0269881113513850 – volume: 179 start-page: 218 year: 2005 ident: 10.1124/jpet.114.222463_bib9 article-title: The effect of the mGlu5 receptor antagonist MPEP in rodent tests of anxiety and cognition: a comparison publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-005-2211-9 – volume: 28 start-page: 633 year: 1997 ident: 10.1124/jpet.114.222463_bib29 article-title: The pharmacology of excitatory and inhibitory amino acid-mediated events in the transmission and modulation of pain in the spinal cord publication-title: Gen Pharmacol doi: 10.1016/S0306-3623(96)00359-X – volume: 75 start-page: 189 year: 2014 ident: 10.1124/jpet.114.222463_bib71 article-title: Chronic metabotropic glutamate receptor 5 inhibition corrects local alterations of brain activity and improves cognitive performance in fragile X mice publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2013.05.038 – volume: 6 start-page: 169 year: 1996 ident: 10.1124/jpet.114.222463_bib77 article-title: 5HT2C receptor agonists exhibit antidepressant-like properties in the anhedonia model of depression in rats publication-title: Eur Neuropsychopharmacol doi: 10.1016/0924-977X(96)00015-6 – volume: 46 start-page: 204 year: 2003 ident: 10.1124/jpet.114.222463_bib22 article-title: 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity publication-title: J Med Chem doi: 10.1021/jm025570j – volume: 2 start-page: 129 year: 1982 ident: 10.1124/jpet.114.222463_bib85 article-title: Treatment of anxiety using fenobam (a nonbenzodiazepine) in a double-blind standard (diazepam) placebo-controlled study publication-title: J Clin Psychopharmacol doi: 10.1097/00004714-198204000-00010 – volume: 15 start-page: 836 year: 2012 ident: 10.1124/jpet.114.222463_bib48 article-title: Preso1 dynamically regulates group I metabotropic glutamate receptors publication-title: Nat Neurosci doi: 10.1038/nn.3103 – volume: 110 start-page: 19 year: 2013 ident: 10.1124/jpet.114.222463_bib66 article-title: Peripheral antinociceptive action of mangiferin in mouse models of experimental pain: role of endogenous opioids, K(ATP)-channels and adenosine publication-title: Pharmacol Biochem Behav doi: 10.1016/j.pbb.2013.05.016 – volume: 16 start-page: 1236 year: 1996 ident: 10.1124/jpet.114.222463_bib4 article-title: Reduced transit-time sensitivity in noninvasive magnetic resonance imaging of human cerebral blood flow publication-title: J Cereb Blood Flow Metab doi: 10.1097/00004647-199611000-00019 – volume: 45 start-page: 54 year: 2013 ident: 10.1124/jpet.114.222463_bib38 article-title: Monoamine neurocircuitry in depression and strategies for new treatments publication-title: Prog Neuropsychopharmacol Biol Psychiatry doi: 10.1016/j.pnpbp.2013.04.009 – volume: 102 start-page: 64 year: 2012 ident: 10.1124/jpet.114.222463_bib47 article-title: Blockade of metabotropic glutamate receptors inhibits cognition and neurodegeneration in an MPTP-induced Parkinson’s disease rat model publication-title: Pharmacol Biochem Behav doi: 10.1016/j.pbb.2012.03.022 – volume: 3 start-page: 823 year: 1986 ident: 10.1124/jpet.114.222463_bib40 article-title: RARE imaging: a fast imaging method for clinical MR publication-title: Magn Reson Med doi: 10.1002/mrm.1910030602 – volume: 285 start-page: 22 year: 1998 ident: 10.1124/jpet.114.222463_bib55 article-title: Role of spinal glutamatergic transmission in the ascending limb of the micturition reflex pathway in the rat publication-title: J Pharmacol Exp Ther doi: 10.1016/S0022-3565(24)37366-5 – volume: 59 start-page: 13 issue: 5, Suppl 1 year: 2002 ident: 10.1124/jpet.114.222463_bib15 article-title: Central pathways controlling micturition and urinary continence publication-title: Urology doi: 10.1016/S0090-4295(01)01633-8 – volume: 321 start-page: 1208 year: 2007 ident: 10.1124/jpet.114.222463_bib10 article-title: Characterization of the antinociceptive actions of bicifadine in models of acute, persistent, and chronic pain publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.106.116483 – volume: 31 start-page: 34 year: 2008 ident: 10.1124/jpet.114.222463_bib75 article-title: Selective 5HT2A and 5HT6 receptor antagonists promote sleep in rats publication-title: Sleep doi: 10.1093/sleep/31.1.34 – volume: 179 start-page: 292 year: 2005 ident: 10.1124/jpet.114.222463_bib101 article-title: Effects of the mGluR2/3 agonist LY354740 on computerized tasks of attention and working memory in marmoset monkeys publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-004-2126-x – volume: 52 start-page: 6 year: 2012 ident: 10.1124/jpet.114.222463_bib28 article-title: Efficacy of antidepressants as analgesics: a review publication-title: J Clin Pharmacol doi: 10.1177/0091270010394852 – volume: 62 start-page: 411 year: 2011 ident: 10.1124/jpet.114.222463_bib57 article-title: Toward fulfilling the promise of molecular medicine in fragile X syndrome publication-title: Annu Rev Med doi: 10.1146/annurev-med-061109-134644 – volume: 47 start-page: 698 year: 2006 ident: 10.1124/jpet.114.222463_bib6 article-title: Radiosynthesis and preclinical evaluation of 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5 publication-title: J Nucl Med – volume: 3 start-page: 199 year: 2012 ident: 10.1124/jpet.114.222463_bib88 article-title: Translational Concepts of mGluR5 in Synaptic Diseases of the Brain publication-title: Front Pharmacol doi: 10.3389/fphar.2012.00199 – volume: 18 start-page: 123 year: 2008 ident: 10.1124/jpet.114.222463_bib54 article-title: mGlu5 receptor antagonists and their therapeutic potential publication-title: Expert Opin Ther Patients doi: 10.1517/13543776.18.2.123 – volume: 50 start-page: 355 year: 1992 ident: 10.1124/jpet.114.222463_bib44 article-title: An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat publication-title: Pain doi: 10.1016/0304-3959(92)90041-9 – volume: 75 start-page: 19 year: 2013 ident: 10.1124/jpet.114.222463_bib39 article-title: Neurophysiological signals as potential translatable biomarkers for modulation of metabotropic glutamate 5 receptors publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2013.06.020 – ident: 10.1124/jpet.114.222463_bib2 doi: 10.1007/s00213-014-3746-4 – volume: 450 start-page: 12 year: 2009 ident: 10.1124/jpet.114.222463_bib49 article-title: The role of metabotropic glutamate receptor mGlu5 in control of micturition and bladder nociception publication-title: Neurosci Lett doi: 10.1016/j.neulet.2008.11.026 – volume: 349 start-page: 155 year: 2014 ident: 10.1124/jpet.114.222463_bib105 article-title: mGluR5 antagonist-induced psychoactive properties: MTEP drug discrimination, a pharmacologically selective non-NMDA effect with apparent lack of reinforcing properties publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.113.211185 – volume: 98 start-page: 205 year: 2011 ident: 10.1124/jpet.114.222463_bib16 article-title: Manifestations and functional implications of sleep homeostasis publication-title: Handb Clin Neurol doi: 10.1016/B978-0-444-52006-7.00013-7 – volume: 4 start-page: 351 year: 2002 ident: 10.1124/jpet.114.222463_bib76 article-title: Simulating the anhedonia symptom of depression in animals publication-title: Dialogues Clin Neurosci doi: 10.31887/DCNS.2002.4.4/jlmoreau – volume: 73 start-page: 381 year: 2002 ident: 10.1124/jpet.114.222463_bib86 article-title: Differential effects of mGluR1 and mGlur5 antagonism on spatial learning in rats publication-title: Pharmacol Biochem Behav doi: 10.1016/S0091-3057(02)00829-8 – volume: 213 start-page: 533 year: 2011 ident: 10.1124/jpet.114.222463_bib37 article-title: FLASH imaging: rapid NMR imaging using low flip-angle pulses. 1986 publication-title: J Magn Reson doi: 10.1016/j.jmr.2011.09.021 – volume: 379 start-page: 1045 year: 2012 ident: 10.1124/jpet.114.222463_bib60 article-title: Major depressive disorder: new clinical, neurobiological, and treatment perspectives publication-title: Lancet doi: 10.1016/S0140-6736(11)60602-8 – volume: 6 start-page: 682 year: 1995 ident: 10.1124/jpet.114.222463_bib79 article-title: Chronic mild stress-induced anhedonia model of depression; sleep abnormalities and curative effects of electroshock treatment publication-title: Behav Pharmacol doi: 10.1097/00008877-199511000-00003 – volume: 74 start-page: 49 year: 2012 ident: 10.1124/jpet.114.222463_bib72 article-title: Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice publication-title: Neuron doi: 10.1016/j.neuron.2012.03.009 – volume: 24 start-page: S468 issue: Suppl 2 year: 2014 ident: 10.1124/jpet.114.222463_bib93 article-title: P.2.f.027 The efficacy and safety of basimglurant as adjunctive therapy in major depression; a randomised, double-blind, placebo-controlled study (Abstract) publication-title: Eur Neuropsychopharmacol doi: 10.1016/S0924-977X(14)70748-5 – volume: 23 start-page: 1051 year: 1995 ident: 10.1124/jpet.114.222463_bib109 article-title: Metabolism of mofarotene in hepatocytes and liver microsomes from different species. Comparison with in vivo data and evaluation of the cytochrome P450 isoenzymes involved in human biotransformation publication-title: Drug Metab Dispos doi: 10.1016/S0090-9556(25)06747-9 – volume: 28 start-page: 1838 year: 2013 ident: 10.1124/jpet.114.222463_bib104 article-title: AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study publication-title: Mov Disord doi: 10.1002/mds.25561 – volume: 66 start-page: 202 year: 2013 ident: 10.1124/jpet.114.222463_bib50 article-title: Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depression publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2012.04.007 – volume: 61 start-page: 1451 year: 2009 ident: 10.1124/jpet.114.222463_bib17 article-title: Validation of cerebral blood perfusion imaging as a modality for quantitative pharmacological MRI in rats publication-title: Magn Reson Med doi: 10.1002/mrm.21779 – volume: 435 start-page: 161 year: 2002 ident: 10.1124/jpet.114.222463_bib102 article-title: Pharmacological and endocrinological characterisation of stress-induced hyperthermia in singly housed mice using classical and candidate anxiolytics (LY314582, MPEP and NKP608) publication-title: Eur J Pharmacol doi: 10.1016/S0014-2999(01)01562-X – volume: 219 start-page: 271 year: 2012 ident: 10.1124/jpet.114.222463_bib59 article-title: Transient mGlu5R inhibition enhances the survival of granule cell precursors in the neonatal cerebellum publication-title: Neuroscience doi: 10.1016/j.neuroscience.2012.05.064 – volume: 223 start-page: 219 year: 2012 ident: 10.1124/jpet.114.222463_bib65 article-title: Metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine produces antidepressant effects in rats: role of brain-derived neurotrophic factor publication-title: Neuroscience doi: 10.1016/j.neuroscience.2012.08.010 – volume: 897 start-page: 171 year: 2012 ident: 10.1124/jpet.114.222463_bib11 article-title: Characterization of G-protein coupled receptor modulators using homogeneous cAMP assays publication-title: Methods Mol Biol doi: 10.1007/978-1-61779-909-9_8 – start-page: 397 year: 2011 ident: 10.1124/jpet.114.222463_bib83 article-title: Drug therapy of depression and anxiety disorders – volume: 11 start-page: 655 year: 2008 ident: 10.1124/jpet.114.222463_bib33 article-title: mGluR5 antagonists: discovery, characterization and drug development publication-title: Curr Opin Drug Discov Devel – volume: 46 start-page: 907 year: 2004 ident: 10.1124/jpet.114.222463_bib41 article-title: Pharmacological manipulation of mGlu2 receptors influences cognitive performance in the rodent publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2004.01.018 – volume: 65 start-page: 1611 year: 2013 ident: 10.1124/jpet.114.222463_bib73 article-title: Neuronal and immunological basis of action of antidepressants in chronic pain—clinical and experimental studies publication-title: Pharmacol Rep doi: 10.1016/S1734-1140(13)71522-6 – volume: 43 start-page: 181 year: 2002 ident: 10.1124/jpet.114.222463_bib89 article-title: Multiple MPEP administrations evoke anxiolytic- and antidepressant-like effects in rats publication-title: Neuropharmacology doi: 10.1016/S0028-3908(02)00082-5 – volume: 295 start-page: 1120 year: 2000 ident: 10.1124/jpet.114.222463_bib25 article-title: Antidepressant-like behavioral effects mediated by 5-hydroxytryptamine(2C) receptors publication-title: J Pharmacol Exp Ther doi: 10.1016/S0022-3565(24)39013-5 – volume: 319 start-page: 254 year: 2006 ident: 10.1124/jpet.114.222463_bib63 article-title: Metabotropic glutamate 5 receptor antagonism is associated with antidepressant-like effects in mice publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.106.103143 – volume: 315 start-page: 711 year: 2005 ident: 10.1124/jpet.114.222463_bib92 article-title: Fenobam: a clinically validated nonbenzodiazepine anxiolytic is a potent, selective, and noncompetitive mGlu5 receptor antagonist with inverse agonist activity publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.105.089839 – volume: 168 start-page: 114 year: 2011 ident: 10.1124/jpet.114.222463_bib74 article-title: Toward neurotrophin-based therapeutics publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.2010.10111677 – ident: 10.1124/jpet.114.222463_bib53 doi: 10.1021/jm501642c – year: 1986 ident: 10.1124/jpet.114.222463_bib84 – volume: 34 start-page: 13 year: 2002 ident: 10.1124/jpet.114.222463_bib81 article-title: Neurobiology of depression publication-title: Neuron doi: 10.1016/S0896-6273(02)00653-0 – start-page: 183 year: 2010 ident: 10.1124/jpet.114.222463_bib12 article-title: Long-term effects of antidepressants on sleep – volume: 15 start-page: 805 year: 2012 ident: 10.1124/jpet.114.222463_bib94 article-title: Preso1, mGluR5 and the machinery of pain publication-title: Nat Neurosci doi: 10.1038/nn.3118 – volume: 8 start-page: 20 year: 2012 ident: 10.1124/jpet.114.222463_bib24 article-title: Metabotropic glutamate receptor 5 (mGluR5) regulates bladder nociception publication-title: Mol Pain doi: 10.1186/1744-8069-8-20 – volume: 13 start-page: 219 year: 1997 ident: 10.1124/jpet.114.222463_bib67 article-title: Differential plasma membrane distribution of metabotropic glutamate receptors mGluR1 alpha, mGluR2 and mGluR5, relative to neurotransmitter release sites publication-title: J Chem Neuroanat doi: 10.1016/S0891-0618(97)00051-3 – volume: 62 start-page: 63 year: 2012 ident: 10.1124/jpet.114.222463_bib97 article-title: Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2011.07.036 – volume: 62 start-page: 92 year: 2007 ident: 10.1124/jpet.114.222463_bib45 article-title: Enhanced long-term synaptic depression in an animal model of depression publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2006.07.007 – volume: 18 start-page: 321 year: 2003 ident: 10.1124/jpet.114.222463_bib80 article-title: Structure-activity relationship of oxadiazoles and allylic structures in the Ames test: an industry screening approach publication-title: Mutagenesis doi: 10.1093/mutage/geg006 – start-page: 165 year: 2010 ident: 10.1124/jpet.114.222463_bib1 article-title: The association between sleep disorders and depression: implications for treatment – volume: 38 start-page: 1493 year: 1999 ident: 10.1124/jpet.114.222463_bib34 article-title: 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist publication-title: Neuropharmacology doi: 10.1016/S0028-3908(99)00082-9 – volume: 63 start-page: 856 year: 2006 ident: 10.1124/jpet.114.222463_bib115 article-title: A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.63.8.856 – volume: 58 start-page: 683 year: 2010 ident: 10.1124/jpet.114.222463_bib23 article-title: From synapse to nucleus: novel targets for treating depression publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2009.12.004 – volume: 40 start-page: 18 year: 2013 ident: 10.1124/jpet.114.222463_bib20 article-title: Effects of MPEP, a selective metabotropic glutamate mGlu5 ligand, on sleep and wakefulness in the rat publication-title: Prog Neuropsychopharmacol Biol Psychiatry doi: 10.1016/j.pnpbp.2012.09.011 – volume: 20C start-page: 124 year: 2015 ident: 10.1124/jpet.114.222463_bib98 article-title: Metabotropic glutamate receptor 5 as drug target for Fragile X syndrome publication-title: Curr Opin Pharmacol doi: 10.1016/j.coph.2014.11.004 – volume: 39 start-page: 1664 year: 2014 ident: 10.1124/jpet.114.222463_bib99 article-title: Long-term memory deficits are associated with elevated synaptic ERK1/2 activation and reversed by mGluR5 antagonism in an animal model of autism publication-title: Neuropsychopharmacology doi: 10.1038/npp.2014.13 – volume: 14 start-page: 609 year: 2013 ident: 10.1124/jpet.114.222463_bib96 article-title: The brain reward circuitry in mood disorders publication-title: Nat Rev Neurosci doi: 10.1038/nrn3381 |
| SSID | ssj0014463 |
| Score | 2.4630165 |
| Snippet | Major depressive disorder (MDD) is a serious public health burden and a leading cause of disability. Its pharmacotherapy is currently limited to modulators of... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 213 |
| SubjectTerms | Allosteric Regulation Animals Anti-Anxiety Agents - pharmacokinetics Anti-Anxiety Agents - pharmacology Anti-Anxiety Agents - therapeutic use Antidepressive Agents - pharmacokinetics Antidepressive Agents - pharmacology Antidepressive Agents - therapeutic use Biogenic Monoamines - metabolism Brain - metabolism Cells, Cultured Cricetulus Depression - drug therapy Depression - metabolism Depression - psychology Drug Inverse Agonism Electroencephalography Female Imidazoles - pharmacokinetics Imidazoles - pharmacology Imidazoles - therapeutic use Macaca fascicularis Male Mice Pain - drug therapy Pain - physiopathology Pyridines - pharmacokinetics Pyridines - pharmacology Pyridines - therapeutic use Radioligand Assay Rats, Sprague-Dawley Rats, Wistar Receptor, Metabotropic Glutamate 5 - antagonists & inhibitors Receptor, Metabotropic Glutamate 5 - metabolism Urinary Bladder, Overactive - drug therapy Urinary Bladder, Overactive - physiopathology |
| Title | Pharmacology of Basimglurant (RO4917523, RG7090), a Unique Metabotropic Glutamate Receptor 5 Negative Allosteric Modulator in Clinical Development for Depression |
| URI | https://dx.doi.org/10.1124/jpet.114.222463 https://www.ncbi.nlm.nih.gov/pubmed/25665805 https://www.proquest.com/docview/1661990490 |
| Volume | 353 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1521-0103 dateEnd: 20240930 omitProxy: true ssIdentifier: ssj0014463 issn: 0022-3565 databaseCode: KQ8 dateStart: 19970101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1521-0103 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0014463 issn: 0022-3565 databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELaq5cIF8aa8NEhotahNSWMnaY7LAluxlGdX2lvkJM6qUjepuukB_g0_kP_AjJ2HC1SCvUSNm9Rx5qtnxp75hrHnyZgrgWrPSVNXOajxhSNVIhzUzIEIVR7muiTL7EMwPRXvzvyzXu-nFbW0qZJR-v2veSVXkSq2oVwpS_Y_JNv-KDbgZ5QvHlHCePwnGX_qeKf1Rvkrebm4OF9uUP9oHtEvHwX6ST6xJuCLPA7dyEXPXwdskrFJzK0zVSEMqnW5WqSDY3xYiSYs1XKgcJdyPfBxGjw35OCHyyVlhFDo_azMqOyXjmUfHDXJlVYAko5efN1E2Ra2Cdwlo2kzeGWPgVbxt2oOWOlhrfFPywjqoi7u_B6RJtsAY4qLrYs5m3yywXTUbTVhg6ag_KpQd-uZrfv2ZEMaJzWhSvQel_Z6yNi3wmj0Il2TqLMVR1onLZiyFM3Ezw1N8RbCm2mcWxaBZ6g6_lQ2niBlg94NMS6PPOLm451ebaMdaUPco87RWkL3lqhPr3lhEFDBjZPP3aYXeua8JbfHy2smKuzm5W-d7DKidjlJ2lia32Q3avHCoYHsLdZTxW22X8P12xDmlliHsA82kO-wH_YplDnYuIaDFtVDMJh-MQQJBs9g4xlaPEODZ_ChwTN0eIYWz7AooMEzWHgGxDN0eL7LTt--mR9NnbqUiJPykFfOxEtllkdy4kt3IoSSPEw8EUZJQmsQkyQLsyCLoixCfcYjdAqCwI0kbSGnOKIk5PfYXlEW6gGDhEowKLpGeiJHA97nmRe5Ck_Hk4z7fTZqZBOnNc8-lXtZxtrf9kRMwiQ2gNgIs88O2htWhmJm96VeI-y4tpCN5RsjJnff9KyBRYy6gzYEZaHKzWU8RuMc8Sgit8_uG7y0T4CuEI7N9R9epctH7Hr313zM9qr1Rj1B471KnmrI_wK1GfBW |
| linkProvider | Colorado Alliance of Research Libraries |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pharmacology+of+Basimglurant+%28RO4917523%2C+RG7090%29%2C+a+Unique+Metabotropic+Glutamate+Receptor+5+Negative+Allosteric+Modulator+in+Clinical+Development+for+Depression&rft.jtitle=The+Journal+of+pharmacology+and+experimental+therapeutics&rft.au=Lindemann%2C+Lothar&rft.au=Porter%2C+Richard+H.&rft.au=Scharf%2C+Sebastian+H.&rft.au=Kuennecke%2C+Basil&rft.date=2015-04-01&rft.pub=Elsevier+Inc&rft.issn=0022-3565&rft.volume=353&rft.issue=1&rft.spage=213&rft.epage=233&rft_id=info:doi/10.1124%2Fjpet.114.222463&rft.externalDocID=S0022356524189902 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3565&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3565&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3565&client=summon |